MarginsXMarginsX
Home › Markets › CVSI

CV Sciences, Inc. (CVSI)

CVSI is quoted over the counter, not listed on an exchange. CV Sciences, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0096
-4.0% on the day
1-year return
-68.0%
Market cap
$2.3M
Nano cap. From the Nov 16, 2026 close × 242.2M shares (10-Q cover page, Nov 5, 2026)
P/E and P/S
Net loss over the period · 0.2×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerCVSI, quoted over the counter
SEC CIK0001510964
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressSan Diego, CA
Incorporated inDE

Warning signs

Cash runway
21.7 months
$308K cash at September 30, 2026
Share count, 1 year
+31.4%
2025-11-11 to 2026-11-05 · +56.6% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$115K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The Company's financial operating results and accumulated deficit, amongst other factors, raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$308K cash; operating cash flow -$43K a quarter.Report 2026-09-30
Shares outstanding242,184,128 (2026-11-05); 184,263,663 a year earlier; 154,604,789 three years earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHaskell & White LLP, Irvine, California, United StatesPCAOB Form AP 2026-04-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $115K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$3.0M-$93K$63K$308K$0$12.5M10-Q 2026-11-13
Q2 2026
2026-06-30
$3.0M-$775K$20K$266K$18K$12.7M10-Q 2026-08-13
Q1 2026
2026-03-31
$3.2M-$643K$101K$309K$72K$13.4M10-Q 2026-05-15
Q4 2025
2025-12-31
$3.3M-$206K-$354K$278K$1.6M$13.8M10-K 2026-03-26
Q3 2025
2025-09-30
$3.3M-$382K-$259K$381K$1.3M$14.4M10-Q 2026-11-13
Q2 2025
2025-06-30
$3.6M-$261K$287K$886K$1.5M$15.0M10-Q 2026-08-13
Q1 2025
2025-03-31
$3.6M-$109K-$81K$812K$1.7M$15.3M10-Q 2026-05-15
Q4 2024
2024-12-31
$3.9M-$726K-$164K$454K$677K$15.7M10-K 2026-03-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52022-03-31
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-04-15

Source: SEC EDGAR submissions feed, 434 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier